A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

Two months after the bone scan, CT-guided biopsy of the thoracic spine lesion confirmed plasmacytoma ... patients with chemorefractory multiple myeloma, even at the stage of terminal illness ...

Osteolytic bone disease is a frequent complication of multiple myeloma ... spinal cord compression and hypercalcemia. It correlates with quality of life and survival. Osteolytic bone lesions ...

Myeloma develops due to the accumulation of multiple pathological genetic events ... chain variable region constitute primary genetic lesions. These primary lesions co-operate with secondary ...

DARZALEX FASPRO ® is a prescription medicine used to treat adult patients with multiple myeloma: · in combination with the medicines bortezomib, lenalidomide, and dexamethasone in newly ...